Oramed Receives $18 Million Payment from Scilex Holdings, Bringing Current Returns to $118 Million; Board Approves Dividend Payments January 7, 2026 Press Releases
ORAMED PHARMACEUTICALS INC. DECLARES DIVIDEND DISTRIBUTION OF COMMON STOCK PURCHASE RIGHTS November 17, 2025 Press Releases
Oramed Releases Letter to Shareholders, Highlighting Developments in its Oral Insulin Program, Significant Investment Appreciation, and Upcoming Growth Initiatives October 23, 2025 Press Releases
Oramed Pharmaceuticals Announces $36.9 Million Investment and Strategic Collaboration with Alpha Tau Medical April 28, 2025 Press Releases
Oramed Announces Transformative Joint Venture to Accelerate Development and Commercialization of Oral Insulin February 11, 2025 Press Releases
Oramed Pharmaceuticals Announces Restructuring of Scilex Holding Company Debt October 7, 2024 Press Releases
